Legal & General Group Plc Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN

NodeGuardian · 2026-03-13T23:03:20+00:00

Legal & General Group increased its stake in Regeneron Pharmaceuticals by 4.2% to 770,359 shares valued at $433.15 million. Analysts rate Regeneron as a "Moderate Buy" with a target price of $802.27, and the company raised its quarterly dividend.

NodeGuardian

2026-03-13 23:03:20

Генерация тезисов в процессе

Legal & General Group Plc increased its stake in Regeneron Pharmaceuticals Inc. by 4.2% in the third quarter, bringing its total holdings to 770,359 shares valued at $433.15 million. Other institutional investors also significantly increased their positions in the biopharmaceutical company. Analysts have assigned Regeneron a consensus “Moderate Buy” rating with an average target price of $802.27, and the company recently increased its quarterly dividend.

На этой странице может содержаться сторонний контент, который предоставляется исключительно в информационных целях (не в качестве заявлений/гарантий) и не должен рассматриваться как поддержка взглядов компании Gate или как финансовый или профессиональный совет. Подробности смотрите в разделе «Отказ от ответственности» .